Skip directly to content

Pfizer in the UK

Working together for Britain’s national health 

Pfizer is one of the world’s premier innovative biopharmaceutical companies, discovering, developing and providing over 120 different medicines, vaccines and consumer healthcare products to help save and improve the lives of millions of people in the UK and around the world every year.

For information about Pfizer in the UK, download our factsheet

Together works better

We firmly believe that innovation comes from working alongside others in effective partnership. We work with organisations from across the UK healthcare spectrum, including the NHS, healthcare providers, academia, patient organisations, non-governmental organisations (NGOs) and UK government, sharing knowledge, skills and expertise to improve the health and lives of people in the UK and around the world.  

Read more about how we work with others

Our business in the UK

The UK remains an important location for Pfizer's research and development and global advanced manufacturing operations. We have around 2,500 colleagues in four locations in the UK working across our commercial business, research and development (R&D) and manufacturing, packaging and distribution.

The company in the UK operates through three divisions, which work closely together to help people live longer and healthier lives:

Pharmaceutical Research and Development in the UK

At Pfizer we invest time, knowledge, money and people to find new life-saving or life-changing medicines. We have more than 800 scientists, researchers and doctors in the UK, all working on the goal of finding new medicines and treatments and getting them safely to healthcare professionals and patients, to improve people’s health.

Our research and development colleagues in the UK work with universities and academia, other companies and other organisations - as well as other Pfizer colleagues across the world - in the search for, and development of, new medicines and treatments.

As of 31 December 2013, Pfizer was conducting 75 ongoing clinical trials at 331 sites in the UK, involving nearly 2,500 patients.  

Read more about Research & Development in the UK

Commercial business 

Our commercial business is divided into three Business Units, each of which broadly work in different areas of medicine. These Business Units are Global Innovative Pharma (GIP); Global Established Pharma (GEP); and Vaccines, Oncology & Consumer Healthcare (VOC). 

Each Business Unit works with our R&D teams, the regulators, the NHS and healthcare professionals – such as GPs, specialists, nurses and pharmacists – to help get our medicines to the patients who need them.

Through Global Established Pharma, we continue to support the medicines in our portfolio even after they are no longer patent protected, to ensure that the NHS and patients can continue to benefit from them for years to come.

Read more about our Biopharmaceutical Business

Pfizer Global Supply 

Helping ensure our medicines and vaccines are available to the people that need them, Pfizer’s packaging and distribution site in Havant is one of the largest in Europe.

The site is a centre of excellence for cold chain packaging and supply, providing temperature sensitive vaccines and injectable medicines to destinations around the world.

Read more about Havant